SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-050949
Filing Date
2023-02-27
Accepted
2023-02-27 17:05:23
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 d428429d424b5.htm 424B5 367295
2 GRAPHIC g428429g01p00.jpg GRAPHIC 52198
3 GRAPHIC g428429g25p21.jpg GRAPHIC 57373
4 GRAPHIC g428429g71i43.jpg GRAPHIC 147784
5 GRAPHIC g428429g96m62.jpg GRAPHIC 54010
  Complete submission text file 0001193125-23-050949.txt   776770
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-259311 | Film No.: 23676386
SIC: 2834 Pharmaceutical Preparations